John C. Gurley, MD, MBA

New Devices

Inside-Out Upper Body Venous Access: First in Human Experience with a Novel Approach Using the Surfacer System

03/05/2014

Central venous occlusive disease is entirely iatrogenic, highly destructive, and vastly underappreciated by the general medical community.

Central venous occlusive disease...

03/05/2014

Cath Lab Digest

New Devices

Percutaneous Removal of Large, Fresh Thrombus in Central Venous Disease with the AngioVac System

06/04/2014

John C. Gurley , MD, MBA;

We first began using the AngioDynamics AngioVac Cannula and Extracorporeal Circuit (AngioVac System) about a year ago, in order to manage large thrombus burdens that affect the IVC and SVC. In our practice, the role of the AngioVac is to...

We first began using the...

06/04/2014

Cath Lab Digest

Case & Technique

A Novel Technique for Impella Removal From Non-Preclosed Arteries Using Perclose ProGlide Closure Device

04/05/2018

Ryan E. Wilson , MD;

John C. Gurley , MD, MBA;

Vikas Bhalla , MD, MSc, MBA;

Damien Marycz , MD;

Usually the Impella arterial access site (14 French) is preclosed with a Perclose ProGlide vascular closure device (Abbott Vascular). The problem lies in cases of emergency, if the access site is not preclosed, and/or if there is a failure of...

Usually the Impella arterial...

04/05/2018

Cath Lab Digest